Copy For Citation
TAŞBAKAN M. S., GÜNDÜZ C., SAYINER A., ÇİLLİ A., Celenk Karaboga B., ŞAKAR COŞKUN A., ...More
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.46, no.5, pp.1422-1427, 2016 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
46
Issue:
5
-
Publication Date:
2016
-
Doi Number:
10.3906/sag-1507-20
-
Journal Name:
TURKISH JOURNAL OF MEDICAL SCIENCES
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
-
Page Numbers:
pp.1422-1427
-
Keywords:
Procalcitonin, C-reactive protein, treatment, pneumonia, TREATMENT FAILURE, BIOMARKERS, MANAGEMENT, MORTALITY, RISK
-
Dokuz Eylül University Affiliated:
Yes
Abstract
Background/aim: There has been growing interest in the use of serum procalcitonin (PCT) and C-reactive protein (CRP) in patients with community-acquired pneumonia (CAP). The aim of this study was to investigate whether an assessment of fever, leukocyte count, and serum CRP and PCT levels on admission and during follow-up (day 3) provides any information about the clinical outcome in hospitalized patients with CAP.